Insider · CIK 0001780113
Erik Harris
Files at RZLT (Rezolute, Inc.), RARE (Ultragenyx Pharmaceutical Inc.). First filing Mar 4, 2025, latest Mar 4, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RARE: Ultragenyx Pharmaceutical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 55Moderate | sell 6 | RARE Ultragenyx Pharmaceutical Inc. | $636k | 15,103 | -15% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | RZLT Rezolute, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Mar 26, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Common Stock | +16,813 | $0.00 | $0 | 83,976 | Mar 4, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Common Stock | +18,443 | $0.00 | $0 | 102,419 | Mar 4, 2025 |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stock | -15,103 | $42.10 | $636k | 87,855 | Mar 4, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,246 | $0.00 | $0 | 30,246 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.